Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  omalizumab
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Omalizumab in Reducing Refractory Type I Hypersensitivity Reactions in Patients with Cancer Receiving Chemotherapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 13-485, NCI-2014-02030, NCT02118987
Start Over